These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis. Hemphill LC J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676 [TBL] [Abstract][Full Text] [Related]
3. Heterozygous familial hypercholesterolemia: a new point-mutation (1372del2) in the LDL-receptor gene which causes severe hypercholesterolemia. Widhalm K; Iro C; Lindemayr A; Schmidt H; Kostner G Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502834 [No Abstract] [Full Text] [Related]
4. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period]. Altinel E; Cetinkaya S; Kara C; Orün UA; Aydin H; Kutsal A Anadolu Kardiyol Derg; 2008 Jun; 8(3):231-2. PubMed ID: 18524734 [No Abstract] [Full Text] [Related]
5. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge. Vuorio AF; Kovanen PT; Gylling H Expert Rev Cardiovasc Ther; 2004 May; 2(3):405-15. PubMed ID: 15151486 [TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial. Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607 [TBL] [Abstract][Full Text] [Related]
8. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Gidding SS; Champagne MA; de Ferranti SD; Defesche J; Ito MK; Knowles JW; McCrindle B; Raal F; Rader D; Santos RD; Lopes-Virella M; Watts GF; Wierzbicki AS; Circulation; 2015 Dec; 132(22):2167-92. PubMed ID: 26510694 [No Abstract] [Full Text] [Related]
9. Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia. Sposito AC; Gonbert S; Bruckert E; Atassi M; Beucler I; Amsellem S; Khallouf O; Benlian P; Turpin G Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2078-82. PubMed ID: 14512370 [TBL] [Abstract][Full Text] [Related]
10. Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body in familial hypercholesterolemia. Jin H; Yao F; Li ZG; Xu ZY Thorac Cardiovasc Surg; 2009 Aug; 57(5):303-4. PubMed ID: 19629894 [TBL] [Abstract][Full Text] [Related]
11. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Robinson JG; Goldberg AC; J Clin Lipidol; 2011 Jun; 5(3 Suppl):S18-29. PubMed ID: 21600526 [No Abstract] [Full Text] [Related]
12. Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Ito MK; McGowan MP; Moriarty PM; J Clin Lipidol; 2011 Jun; 5(3 Suppl):S38-45. PubMed ID: 21600528 [No Abstract] [Full Text] [Related]
13. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia. van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095 [TBL] [Abstract][Full Text] [Related]
15. [Hydroxymethylglutaryl CoA reductase inhibitors. A new group of substances for lowering a high cholesterol level]. Uhl D Med Monatsschr Pharm; 1988 Oct; 11(10):326-30. PubMed ID: 3185357 [No Abstract] [Full Text] [Related]